Skip to main content
FDMT
NASDAQ Life Sciences

Q3 Loss Widens to $78M, Missing Estimates as Operating Expenses Hit $85M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$12.05
Mkt Cap
$669.284M
52W Low
$6.96
52W High
$16.93
52W Position info
73% above low
Off High info
29% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

FDMT sits 73% above its 52-week low of $6.96.

Summary

4D Molecular Therapeutics posted a Q3 net loss of $78.056 million, or -$1.08 per basic share, worse than the IBES estimate of -$74.2 million. Revenue of $4.145 million beat the $2.7 million estimate, but operating expenses of $85.363 million drove an operating loss of $81.218 million versus the -$79 million consensus. The loss widened from the $72.9 million net loss reported in Q2, when R&D spending rose 42% to $68.3 million. Cash and marketable securities stood at $430.6 million as of the last quarterly filing, giving the company at least a year of runway while it funds the 4SIGHT Phase 3 trial of 4D-150 in diabetic macular edema, which enrolled its first patients in late September.

At the time of this announcement, FDMT was trading at $12.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $669.3M. The 52-week trading range was $6.96 to $16.93. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FDMT - Latest Insights

FDMT
Sep 28, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.30
Real-time Price: $11.95 info
Change: -$2.35 (-16%) info
Market Cap: $660.168M info
FDMT
Sep 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $14.30
Real-time Price: $11.95 info
Change: -$2.35 (-16%) info
Market Cap: $660.168M info
FDMT
Aug 13, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.32
Real-time Price: $11.95 info
Change: +$0.630 (+6%) info
Market Cap: $660.168M info
FDMT
Jul 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.30
Real-time Price: $11.95 info
Change: +$0.650 (+6%) info
Market Cap: $660.168M info
FDMT
Jul 18, 2026, 3:15 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $10.29
Real-time Price: $11.95 info
Change: +$1.66 (+16%) info
Market Cap: $660.168M info